Oseltamivir for pandemic influenza preparation: Maximizing the use of an existing stockpile.
نویسندگان
چکیده
With the threat of significant morbidity and mortality following an influenza pandemic, stockpiling of antiviral agents such as oseltamivir is recommended. Shelf-life extension was explored to maximize use of an existing stockpile. This analysis demonstrated that oseltamivir retains potency defined by United States Pharmacopeia acceptance criteria beyond the labeled expiration date.
منابع مشابه
Oseltamivir storage, distribution and dispensing following the 2009 H1N1 influenza outbreak in Mexico.
PROBLEM During an influenza outbreak or pandemic, timely access to antivirals is essential to reduce disease severity and transmission. Best practices in antiviral procurement, storage, distribution, prescription and dispensing must be followed for prompt drug delivery. APPROACH Mexico implemented a national pandemic preparedness plan in 2006 and created a strategic antiviral stockpile. Oselt...
متن کاملUse of oseltamivir in children.
QUESTION Because of the recent outbreak of pandemic H1N1 2009, I am anticipating a large number of children with influenza-like symptoms or children diagnosed with influenza. Is oseltamivir effective and safe when used for children? ANSWER Oseltamivir is effective for prevention of complications associated with influenza A (including H1N1) in children. Oseltamivir also reduces the duration of...
متن کاملStrategies for the use of oseltamivir and zanamivir during pandemic outbreaks.
BACKGROUND The use of neuraminidase inhibitors (oseltamivir and zanamivir) for the treatment of ill individuals has been an important intervention during the 2009 H1N1 pandemic. However, the emergence and spread of drug resistance remains a major concern and, therefore, optimizing antiviral strategies is crucial to retain the long-term effectiveness of these pharmaceutical interventions. METH...
متن کاملOseltamivir use and outcomes during the 2009 influenza A H1N1 pandemic in Taiwan
BACKGROUND The Taiwan CDC provided free oseltamivir to all patients with influenza infections confirmed by rapid testing or who had clinical warning symptoms during the 2009 H1N1 influenza pandemic in Taiwan. However, oseltamivir utilization patterns, cost, and outcomes among oseltamivir-treated patients remained unclear. METHOD A population-level, observational cohort study was conducted usi...
متن کاملCan We “Hedge” against the Development of Antiviral Resistance among Pandemic Influenza Viruses?
In the May 2009 issue of PLoS Medicine, Wu and colleagues presented the results of a series of mathematical models that examine how the use of influenza antiviral drugs might influence the development of antiviral resistance [1]. Their analyses suggest that a small supplemental stockpile of an alternative antiviral, in addition to a primary stockpiled antiviral (oseltamivir for every country th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- American journal of infection control
دوره 45 3 شماره
صفحات -
تاریخ انتشار 2017